| Main Subject |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Internet and Businesses Online > List Building > List Building - Multiple Targeted Lists are Critical to Your Maximized Success |
|
Main Subject - List Building - Multiple Targeted Lists are Critical to Your Maximized Success
When you are list building, you want your lists to be as tightly targeted as possible. The reason for According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product this is that the tighter your lists are targeted, the more effective your mailings can be to each membe ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in r of your lists. For example, imagine that you have a web site that specializes in pet products. Imag lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. ine that you provide pet products for a wide range of pets, for example, dogs, cats, and birds. If you here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe create one mailing list, you will have dog, cat, and bird owners on your list. When you mail to them, d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro only 1/3 of the offers and information you send will be relevant to each subscriber (assuming you mail ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc 1/3 of your offers on each topic: dogs, cats, and birds). 2/3 of the mailings you do will not be well easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi -received. Your subscribers will begin to feel that your mailing is not relevant to them – even though nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically 1/3 of the offers you sent applied to them. Now imagine that you build 3 separate lists, one for dog and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ owners, one for cat owners, and one for bird owners. In this scenario, assuming that you have exactly ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi the same total subscribers on these 3 lists combined, your response rates will be much higher. The rea ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a son for this is that the dog owners will only receive offers that are relevant to them, as dog owners. dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod And of course the same applies to the cat owners and the bird owners. They will only receive offers t cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin hat make sense to them, and will feel as though the bulk of your emails are relevant to them. Now imag tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen ine that you could break this down even further. Imagine if one your dog lists, you have products that t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel are specifically designed for a specific breed of dog. You could literally have one list for each bre ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust ed of dog. In this case, your conversion rates and response rates should again go up, although the inc y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products rease might be marginal, and not enough to compensate for the additional time that is necessary for the . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de upkeep of the additional multiple lists. So there is some sort of balance that needs to be maintained elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip , although in general, the more tightly you target each list, the more profitable will each list become tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:How Forgetting About Your Profits Can Help Market Your Business Autoresponder Simplicity - Life is Easy with Autoresponders
|